Brief: Geron Announces EC Approval For RYTELO To Treat Transfusion-Dependent Anemia
11/03/2025 20:54
March 11 (Reuters) - Geron Corp GERN.O: GERON CORP: EC APPROVAL FOR RYTELO TO TREAT TRANSFUSION-DEPENDENT ANEMIA IN LOWER-RISK MDS ADULTS Source text: ID:nBw1T3N7a Further company coverage: GERN.O
Recent news on Geron
See all newsBrief: Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Geron Corporation reports results for the quarter ended June 30 - Earnings Summary
Geron's Q2 revenue rises on RYTELO growth
Brief: Geron Q2 EPS USD -0.02
Brief: Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)